Sandoz has announced that the National Institute for Health and Care Excellence (NICE) has recommended Rizmoic® (naldemedine), within its current UK marketing authorisation, as an option for treating opioid-induced constipation (OIC) in adults after previous laxative...
BIG have launched the third edition of the Cost of Constipation report. The report reveals the significant cost of constipation to the NHS and also highlights how the condition can have a damaging impact on patient lives. New in the report for 2020 are: Changes in...
Hear Professor Anton Emmanuel discuss his key takeaways from the updated Cost of Constipation Report. Anton discusses the new figures on admissions to hospital for constipation as well as prescription laxative costs. Anton also looks at the variation in these costs...
This heat map developed as part of the Cost of Constipation Report shows the burden of constipation across England The heat map shows the cost rate of admissions to hospital for constipation per 100,000 population and identifies the regions that are spending more than...
This Interactive Treatment Pathway for chronic constipation has been developed by The Bowel Interest Group. It is an easy reference guide for treating adults with chronic constipation. The interactive treatment pathway starts at the initial consultation through to...
